Form D · Biotechnology
Pulmotect, Inc.
Houston, TX · CIK 0001673929
Offering snapshot reported Sep 9, 2024 · SEC filing
- Reported sold
- $10.3M Indefinite offering
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2024 | Initial | $10,280,435 | No comparison | 15 | SEC filing |
| Jan 16, 2024 | Amendment | $3,661,000 | $150,000vs Feb 10, 2023 | 11 | SEC filing |
| Sep 28, 2023 | Amendment | $1,500,000 | $1,200,000vs Jun 14, 2023 | 2 | SEC filing |
| Jun 14, 2023 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Feb 10, 2023 | Amendment | $3,511,000 | $0vs Jan 27, 2023 | 11 | SEC filing |
| Jan 27, 2023 | Amendment | $3,511,000 | $1,300,000vs Feb 9, 2022 | 11 | SEC filing |
| Feb 9, 2022 | Initial | $2,211,000 | No comparison | 3 | SEC filing |
| Mar 11, 2021 | Initial | $3,500,000 | No comparison | 21 | SEC filing |
| Feb 24, 2020 | Amendment | $6,099,391 | $554,999vs Feb 26, 2019 | 22 | SEC filing |
| Feb 26, 2019 | Amendment | $5,544,392 | $1,544,389vs Mar 7, 2018 | 15 | SEC filing |
| Mar 7, 2018 | Initial | $4,000,003 | No comparison | 1 | SEC filing |
| May 6, 2016 | Initial | $1,751,430 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-523517
Source: Form D, filed Sep 9, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Benedyk | Director |
| Colin Broom | Director, Executive |
| James Gamett | Director |
| Bruce Given | Director |
| Magnus Hook | Director |
| Leo E. Linbeck | Director |
| Leo E. Linbeck Iii | Director |
| William Noss | Executive |
| Brenton Scott | Director |
| Kumar Srinivasan | Director |
| Atul Varadhachary | Director |
| Mark Worscheh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3900 Essex Lane Suite 575
Houston, TX, 77027
Houston, TX, 77027